Effect of Respiratory muscle stretching on pulmonary disease Patients
- Conditions
- Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified
- Registration Number
- CTRI/2020/03/023858
- Lead Sponsor
- Centre for Physiotherapy and Rehabilitation Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Diagnosis of COPD according to Global Initiative for Chronic Obstructive Lung Disease criteria and post bronchodilator results of spirometry of forced expiratory volume in 1 second to forced vital capacity ratio FEV1/FVC ratio less than 0.7.
Patients with moderate and severe classification of COPD ( FEV1 values between 50% and 80% and FEV1 values between 30% and 50%).
Stable and ambulant.
Patient with delayed heart rate recovery after 6mwt
Patients having unstable cardiovascular disease such as heart failure or coronary artery disease.
Patients having pacemaker.
Any musculoskeletal problem that would limit stretching.
Patients taking digoxin, beta blockers, non-dihydropyridine calcium channel blockers or other rate modulated medication.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Heart rate recoveryTimepoint: pre Muscle Training and post Muscle Training
- Secondary Outcome Measures
Name Time Method ot ApplicableTimepoint: Not Applicable